|
Volumn 9, Issue 1, 1999, Pages 39-61
|
New directions in antimicrobial therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B LIPID COMPLEX;
ANTIBIOTIC AGENT;
ANTIFUNGAL AGENT;
ANTIVIRUS AGENT;
AZTREONAM;
BETA LACTAM ANTIBIOTIC;
BETA LACTAMASE INHIBITOR;
CARBAPENEM DERIVATIVE;
CEFOTAXIME;
CEFTAZIDIME;
CEFTRIAXONE;
CEPHALOSPORIN DERIVATIVE;
CILASTATIN PLUS IMIPENEM;
CIPROFLOXACIN;
CLINDAMYCIN;
DALFOPRISTIN PLUS QUINUPRISTIN;
GANCICLOVIR;
LEVOFLOXACIN;
NORFLOXACIN;
OFLOXACIN;
PENICILLIN DERIVATIVE;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RIFAMPICIN;
SULTAMICILLIN;
TROVAFLOXACIN;
TUBERCULOSTATIC AGENT;
UNINDEXED DRUG;
VANCOMYCIN;
ZIDOVUDINE;
ANTIBIOTIC PROPHYLAXIS;
ANTIBIOTIC THERAPY;
ANTIMICROBIAL ACTIVITY;
CANCER;
CHILL;
CYTOMEGALOVIRUS INFECTION;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
HOSPITAL INFECTION;
HUMAN;
HYPOKALEMIA;
INHALATIONAL DRUG ADMINISTRATION;
INTRANASAL DRUG ADMINISTRATION;
MULTIDRUG RESISTANCE;
MYCOSIS;
NEPHROTOXICITY;
OPPORTUNISTIC INFECTION;
ORAL DRUG ADMINISTRATION;
PARENTERAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
REVIEW;
TUBERCULOSIS;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
CROSS INFECTION;
CYTOMEGALOVIRUS INFECTIONS;
DRUG RESISTANCE, MULTIPLE;
HUMANS;
OPPORTUNISTIC INFECTIONS;
TUBERCULOSIS, MULTIDRUG-RESISTANT;
|
EID: 0032971096
PISSN: 10523359
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (78)
|